MRP2 (ABCC2) and cisplatin sensitivity in hepatocytes and human ovarian carcinoma
Alexander Guminski(The University of Sydney), Anna DeFazio(The University of Sydney), Yoke-Eng Chiew(The University of Sydney), Paul R. Harnett(The University of Sydney), Rosemary L. Balleine(The University of Sydney), Michael Tapner(The University of Sydney), Geoffrey C. Farrell(Australian National University), Lucy R. Webster(The University of Sydney)
Cited by 72
Related Papers
Whole–genome characterization of chemoresistant ovarian cancer
|Nature|2015|1.7k
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
|Clinical Cancer Research|2008|1.5k
<i>BRCA</i> Mutation Frequency and Patterns of Treatment Response in <i>BRCA</i> Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
|Journal of Clinical Oncology|2012|1.2k
Driver mutations in <i>TP53</i> are ubiquitous in high grade serous carcinoma of the ovary
|The Journal of Pathology|2010|836